|
|
|
|
| LEADER |
01771nam a2200397Ia 4500 |
| 001 |
EBC3379028 |
| 003 |
MiAaPQ |
| 005 |
20200520144314.0 |
| 006 |
m o d | |
| 007 |
cr cn||||||||| |
| 008 |
111220s2012 dcua sb 000 0 eng d |
| 020 |
|
|
|z 9780309253154
|
| 020 |
|
|
|z 0309253152
|
| 035 |
|
|
|a (MiAaPQ)EBC3379028
|
| 035 |
|
|
|a (Au-PeEL)EBL3379028
|
| 035 |
|
|
|a (CaPaEBR)ebr10606369
|
| 035 |
|
|
|a (CaONFJC)MIL394882
|
| 035 |
|
|
|a (OCoLC)902942425
|
| 040 |
|
|
|a MiAaPQ
|c MiAaPQ
|d MiAaPQ
|
| 050 |
|
4 |
|a R853.C55
|b E585 2012
|
| 245 |
0 |
0 |
|a Envisioning a transformed clinical trials enterprise in the United States
|h [electronic resource] :
|b establishing an agenda for 2020: workshop summary /
|c Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 2012.
|
| 300 |
|
|
|a xvi, 232 p. :
|b ill.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 533 |
|
|
|a Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.
|
| 650 |
|
0 |
|a Clinical trials
|z United States.
|
| 650 |
|
0 |
|a Clinical medicine
|x Research
|z United States.
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Weisfeld, Neil E.
|
| 700 |
1 |
|
|a English, Rebecca A.
|
| 700 |
1 |
|
|a Claiborne, Anne B.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Forum on Drug Discovery, Development, and Translation.
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.).
|b Board on Health Sciences Policy.
|
| 710 |
2 |
|
|a National Academies Press (U.S.)
|
| 710 |
2 |
|
|a ProQuest (Firm)
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/matrademy/detail.action?docID=3379028
|z Click to View
|
